The Federal Trade Commission reached a landmark settlement with Express Scripts over allegations it inflated drug prices, particularly for insulin, to increase profits. The agreement bans practices ...
Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...
Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
The Federal Trade Commission has reached a landmark settlement with pharmacy benefit manager Express Scripts over allegations it inflated drug prices, particularly for insulin, to boost profits. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results